aranesp 40 mcg
amgen europe b.v. - darbepoetin alfa - solution for injection - darbepoetin alfa 40 mcg / 0.4 ml - darbepoetin alfa - aranesp ® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (crf) in adults and paediatric patients ≥ 1 year of age
aranesp 50 mcg
amgen europe b.v. - darbepoetin alfa - solution for injection - darbepoetin alfa 50 mcg / 0.5 ml - darbepoetin alfa - aranesp ® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (crf) in adults and paediatric patients ≥ 1 year of age
aranesp 60 mcg
amgen europe b.v. - darbepoetin alfa - solution for injection - darbepoetin alfa 60 mcg / 0.3 ml - darbepoetin alfa - aranesp ® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (crf) in adults and paediatric patients ≥ 1 year of age
aranesp 300 mcg
amgen europe b.v. - darbepoetin alfa - solution for injection - darbepoetin alfa 300 mcg / 0.6 ml - darbepoetin alfa - aranesp ® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (crf) in adults and paediatric patients ≥ 1 year of age.aranesp ® is indicated for the treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.
aranesp 500 mcg
amgen europe b.v. - darbepoetin alfa - solution for injection - darbepoetin alfa 500 mcg/ml - darbepoetin alfa - aranesp ® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (crf) in adults and paediatric patients ≥ 1 year of age.aranesp ® is indicated for the treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.
repatha solution for injection in pre-filled autoinjector 140mgml
amgen biotechnology singapore pte ltd - evolocumab - injection, solution - evolocumab 140mg/ml
repatha solution for injection in pre-filled syringe 140mgml
amgen biotechnology singapore pte ltd - evolocumab - injection, solution - evolocumab 140 mg/ml
aranesp 80 mcg
amgen europe b.v. - darbepoetin alfa - solution for injection - darbepoetin alfa 80 mcg / 0.4 ml - darbepoetin alfa - aranesp ® is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (crf) in adults and paediatric patients ≥ 1 year of age
xgeva 120mg1.7 ml solution for injection
amgen biopharmaceuticals malaysia sdn bhd - denosumab -
prolia solution for injection 60mgml pre-filled syringe
amgen biopharmaceuticals malaysia sdn bhd - denosumab -